|
"tseng jeng sen"的相关文件
显示项目 26-35 / 56 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2021-07-12T02:24:08Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
SU, SHENG-FANG; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; Yu, Sung-Liang; Li, Ker-Chau |
| 臺大學術典藏 |
2021-05-21T11:40:35Z |
Primary tumor radiotherapy during EGFR-TKI disease control improves survival of treatment Nave advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu, Kuo Hsuan; Huang, Jing Wen; Tseng, Jeng Sen; KUAN-WEN CHEN; Weng, Yih Chyang; SUNG-LIANG YU; Yang, Tsung Ying; Huang, Yen Hsiang; Chen, Jeremy J.W.; Chen, Kun Chieh; Chang, Gee Chen |
| 國立成功大學 |
2021-04-30 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee;Po-Hsin;Yang;Tsung-Ying;Chen;Kun-Chieh;Huang;Yen-Hsiang;Tseng, Jeng-Sen;Hsu;Kuo-Hsuan;Wu;Yu-Chen;Liu;Ko-Jiunn;Chang;Gee-Chen |
| 臺大學術典藏 |
2021-03-15T08:41:47Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Su, Kang-Yi;Sung-Liang Yu;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:38:25Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Kang-Yi Su;Yu, Sung-Liang;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:35:04Z |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Chang, Gee-Chen |
| 國立交通大學 |
2020-07-01T05:22:11Z |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
|
Raghav, Lovely; Chang, Ya-Hsuan; Hsu, Yi-Chiung; Li, Yu-Cheng; Chen, Chih-Yi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chuang, Cheng-Yen; Lee, Mei-Hsuan; Wang, Chih-Liang; Chen, Huei-Wen; Yu, Sung-Liang; Su, Sheng-Fang; Yuan, Shin-Sheng; Chen, Jeremy J. W.; Ho, Shinn-Ying; Li, Ker-Chau; Yang, Pan-Chyr; Chang, Gee-Chen; Chen, Hsuan-Yu |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
|
Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemona?ve patients with EGFR-mutant lung adenocarcinoma
|
MONG-HSUN TSAI; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Jeremy Jw; Su, Kang-Yi; Yu, Sung-Liang; Tsai, Meen-Hsin; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren |
| 臺大學術典藏 |
2020-02-10T09:00:23Z |
Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chang, Gee-Chen; MONG-HSUN TSAI |
显示项目 26-35 / 56 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
|
